The ERCC6 gene helps your cells repair DNA damage in genes that are actively being used, especially after sunlight and other everyday stresses. If it is not working well, cells can struggle to recover from that damage, which may lead to marked sun sensitivity or conditions such as Cockayne syndrome, often linked to poor growth, developmental delay, and hearing or vision problems. Understanding this gene can help make sense of genetic results connected to DNA repair and photosensitivity.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells can use to make molecules or to guide processes in the body. Some genes carry the code for proteins, the parts of cells that do the work. Other genes mainly regulate when certain processes happen, where they happen, and how strongly they operate. Taken together, genes influence how the body develops and functions, and they can affect how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
ERCC6Gene function
What if the gene works
The ERCC6 gene helps cells repair DNA damage that blocks reading genetic instructions. It supports restarting this process, helping cells keep making proteins and working normally.
Risk
What if the gene does not work
Variants in the ERCC6 gene can impair DNA repair. Depending on the variant, this may cause Cockayne syndrome with poor growth, developmental delay, and vision or hearing loss, or a milder condition with marked sun sensitivity.
Treatment
What does that mean for your treatment
No treatment or management approach specifically tied to a pathogenic variant in the ERCC6 gene is currently established. Care is symptom based rather than directed by the gene itself. The ERCC6 gene is being studied as a possible biomarker and drug target in cancer and DNA repair research.
Conditions associated with ERCC6
Gene function
What if the gene works
Your cells use the ERCC6 gene to keep DNA reading and DNA repair working together. It is especially important when damage blocks a gene that the cell is actively using. By helping repair DNA in active genes, this gene supports the steady RNA messages cells need for everyday function.
The ERCC6 gene helps repair DNA damage that blocks genes while they are being read. This targeted pathway is called transcription-coupled repair (repair focused on genes in active use).
When damage stalls the machinery that reads genes, the ERCC6 gene helps organize the response at that spot. It uses cell energy to move nearby DNA and proteins so repair helpers can reach the blockage.
After the blocked area is handled, the ERCC6 gene helps gene reading resume in a controlled way. This supports normal production of RNA (a working copy made from DNA instructions).
What is a variant?
A genetic variant is a slight change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ERCC6 gene can make its protein unstable, less active, or absent, so cells have more trouble clearing DNA damage when the cell's reading machinery gets stuck. Milder variants in the ERCC6 gene may leave some repair activity, while more severe variants can sharply reduce it or stop the protein from working at all. This ERCC6 variant effect on DNA repair can help explain why some people have milder UV-sensitive syndrome, while others develop earlier and broader features of Cockayne syndrome.
How variants are linked to conditions
The clearest ERCC6 gene and disease link is Cockayne syndrome, a rare inherited condition. Pathogenic variants usually need to be inherited from both parents and can lead to poor growth, developmental delay, vision or hearing loss, and features of premature aging. Some variants in the ERCC6 gene are also linked to UV-sensitive syndrome, which mainly causes unusual sensitivity to sunlight without the full Cockayne syndrome pattern.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible association rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ERCC6, the main factor that changes risk is family history: a child is affected when they inherit a harmful ERCC6 change from both parents. In people living with an ERCC6-related condition, strong sun exposure can worsen skin and eye problems, so sun protection helps reduce complications rather than the genetic risk itself.
Inheritance of ERCC6 variants
ERCC6-related conditions are usually inherited in an autosomal recessive pattern. This means a child inherits one altered ERCC6 gene copy from each parent, and parents who carry one copy usually do not have the condition themselves. When both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is also a carrier, and a 25% chance of a child with two working copies. In practical terms, ERCC6 gene inheritance most often means the condition can appear unexpectedly in a family when two healthy carriers have a child together.
What does my ERCC6 result mean for my family?
For ERCC6, family members are usually affected through a recessive pattern, which means parents often carry the gene change without having symptoms themselves. Brothers and sisters may also be affected or may be healthy carriers, and other blood relatives could be carriers too. This can matter for future pregnancies and for relatives who want to understand their own chances of passing the change on.
Genetic information
Genetic testing
How you find out about variants
ERCC6 genetic testing usually uses a blood or saliva sample to look for variants in the ERCC6 gene. A lab reads the gene’s DNA code and compares it with the usual sequence to identify changes, then reports whether a variant was found and whether it is known to help explain a person’s condition.
When should I consider getting a genetic test?
Consider ERCC6 testing when a child has signs of a rare inherited condition, such as very slow growth, developmental delay, hearing or vision problems, and unusual sensitivity to sunlight, or when this pattern runs in the family. It can also help show whether someone carries the family’s ERCC6 gene change.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the specific type of variant. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body responds to medicines. Some people break down or move a drug through the body differently, so the same treatment may work better for one person, have less effect in another, or cause more side effects in someone who is more sensitive. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can shape a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect both how the body processes a drug and how strong its effects may be. This information can support treatment decisions that are more informed and more individualized. You can learn more about this topic in the LearnHub.
Drugs influenced by the ERCC6 gene
When should I seek medical advice?
This gene does not currently have a broadly confirmed role in guiding medication choices, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor. Research on ERCC6 has explored whether changes in this gene may affect response to some cancer treatments, but this is not part of routine care.
History
ERCC6 entered medical genetics through research on Cockayne syndrome, a rare inherited condition first described in the 1930s by Dr. Edward Alfred Cockayne. In the 1990s, researchers identified the ERCC6 gene as the cause of one major form of this condition, often called Cockayne syndrome type B. From these first observations, research expanded steadily, helping doctors separate different genetic forms of Cockayne syndrome that can look similar in daily life. The discovery also strengthened a broader shift in genetics, where rare inherited conditions were increasingly traced to specific genes rather than described only by their visible features. Since then, ERCC6 has remained part of the scientific story of how gene discoveries improved diagnosis for families with unusual growth, hearing, vision, and aging related patterns.